Prevalence of Helicobacter pylori Resistance to Metronidazole, Clarithromycin, Amoxicillin, Tetracycline, and Furazolidone in Brazil
- 1 June 2000
- journal article
- research article
- Published by Wiley in Helicobacter
- Vol. 5 (2) , 79-83
- https://doi.org/10.1046/j.1523-5378.2000.00011.x
Abstract
Background. Helicobacter pylori infection is associated with a wide range of digestive diseases and is very prevalent in developing countries, although few data exist on the susceptibility of H. pyl...Keywords
This publication has 24 references indexed in Scilit:
- Furazolidone‐containing short‐term triple therapies are effective in the treatment of Helicobacter pylori infectionAlimentary Pharmacology & Therapeutics, 1999
- High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 weekAlimentary Pharmacology & Therapeutics, 1999
- Stable amoxicillin resistance in Helicobacter pyloriThe Lancet, 1998
- Addition of bismuth subnitrate to omeprazole plus amoxycillin improves eradication of Helicobacter pyloriAlimentary Pharmacology & Therapeutics, 1998
- Resistance of Helicobacter pylori to antibioticsAlimentary Pharmacology & Therapeutics, 1997
- Eradication of ‘ooHelicobacter pylori‘ox : an objective assessment of current therapiesBritish Journal of Clinical Pharmacology, 1997
- Antimicrobial resistance and Helicobacter pyloriJournal of Antimicrobial Chemotherapy, 1996
- Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitroJournal of Antimicrobial Chemotherapy, 1996
- NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer DiseaseJAMA, 1994
- Duodenal Ulcer and Eradication ofHelicobacter pyloriin a Developing Country An 18-Month Follow-up StudyScandinavian Journal of Gastroenterology, 1992